Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$3 Mln
P/E Ratio
--
P/B Ratio
1.09
Industry P/E
--
Debt to Equity
14.67
ROE
-4.64 %
ROCE
0.05 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$-216.09 Mln
EBITDA
$-203.18 Mln
Net Profit
$-319.47 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Venus Concept (VERO)
| -30.22 | 9.06 | -28.99 | -68.35 | -76.20 | -66.66 | -- |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Venus Concept (VERO)
| -67.79 | -75.42 | -81.18 | -1.73 | -63.19 | -28.07 | -90.41 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.10 | 10,391.68 | 14.66 | 12.69 | |
| 71.01 | 9,766.86 | 94.68 | 2.52 | |
| 277.35 | 10,728.90 | 770.42 | 1.2 | |
| 117.67 | 14,455.82 | 41.45 | 5.44 |
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its... product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thights in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada. Address: 235 Yorkland Boulevard, Toronto, ON, Canada, M2J 4Y8 Read more
President & COO
Dr. Hemanth Jacob Varghese CFA, Ph.D.
President & COO
Dr. Hemanth Jacob Varghese CFA, Ph.D.
Headquarters
Toronto, ON
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Venus Concept Inc (VERO) stood at $ 68 Mln as on 31-Dec-24
The share price of Venus Concept Inc (VERO) is $2.89 (NASDAQ) as of 17-Apr-2025 16:24 EDT. Venus Concept Inc (VERO) has given a return of -76.2% in the last 3 years.
Venus Concept Inc (VERO) has a market capitalisation of $ 3 Mln as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Venus Concept Inc (VERO) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Venus Concept Inc (VERO) and enter the required number of quantities and click on buy to purchase the shares of Venus Concept Inc (VERO).
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thights in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada. Address: 235 Yorkland Boulevard, Toronto, ON, Canada, M2J 4Y8
The CEO & director of Dr. Hemanth Jacob Varghese CFA, Ph.D.. is Venus Concept Inc (VERO), and CFO & Sr. VP is Dr. Hemanth Jacob Varghese CFA, Ph.D..
There is no promoter pledging in Venus Concept Inc (VERO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,126
|
|
|
1,070
|
|
|
1,049
|
|
|
978
|
| Venus Concept Inc. (VERO) | Ratios |
|---|---|
|
Return on equity(%)
|
-0.43
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
0.04
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Venus Concept Inc (VERO) was $0 Mln.
$-0.46
(
